Clinical Trials Browser

Phase 2 × phosphorylethanolamine × Clear all

NCT02950103 2019-09-30

Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients

Phase 2 Terminated

Other solid neoplasm

Solid Tumor